G.ST Antivirals
Series A in 2024
G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
Sarcura
Seed Round in 2022
Sarcura is an Austrian deep-tech company developing an instrument platform for industrial manufacturing of advanced cell therapies. The platform blends silicon chip technology with microfluidic processing to enable real-time process control and manipulation at the cellular level, supporting autonomous, modular, and automated production. It combines semiconductor-based microfluidics, intelligent batch processing, and a scalable system architecture to reduce costs, boost production capacity, and tailor processes for diverse cell types. Founded in 2019 and based in Hinterstoder, Sarcura aims to enable scalable, patient-specific therapies, including cancer treatments, by delivering a compact, autonomous manufacturing system.
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
contextflow
Series A in 2021
contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.
Sarcura
Seed Round in 2020
Sarcura is an Austrian deep-tech company developing an instrument platform for industrial manufacturing of advanced cell therapies. The platform blends silicon chip technology with microfluidic processing to enable real-time process control and manipulation at the cellular level, supporting autonomous, modular, and automated production. It combines semiconductor-based microfluidics, intelligent batch processing, and a scalable system architecture to reduce costs, boost production capacity, and tailor processes for diverse cell types. Founded in 2019 and based in Hinterstoder, Sarcura aims to enable scalable, patient-specific therapies, including cancer treatments, by delivering a compact, autonomous manufacturing system.
Prewave
Seed Round in 2020
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
G.ST Antivirals
Series A in 2020
G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.
Prewave
Pre Seed Round in 2018
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
contextflow
Seed Round in 2018
contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.